Prospective comparison of uPA/PAI-1 and endopredict-clin score in ER-positive, HER2-negative breast cancer: Impact on risk stratification and treatment decisions.

Authors

null

Johannes Ettl

Department of Obstetrics and Gynecology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany

Johannes Ettl , Kirsten Grosse Lackmann , Alexander Hapfelmeier , Evelyn Klein , Stefan Paepke , Christoph Petry , Katja Specht , Heinz Hoefler , Marion Kiechle

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer - HER2/ER

Track

Breast Cancer

Sub Track

ER+

Citation

J Clin Oncol 31, 2013 (suppl; abstr 581)

DOI

10.1200/jco.2013.31.15_suppl.581

Abstract #

581

Poster Bd #

6D

Abstract Disclosures

Similar Posters